ACTINIUM PHARMACEUTICALS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2023-06-30 was $9.79M, a 41.34% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2023-03-31 was $770.00K.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2022-09-30 was $1.58M, a 72.78% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for the quarter ending 2022-06-30 was $16.69M, a 16.53% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2022 was $23.16M, a 34.40% decline from fiscal 2021.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2021 was $35.30M.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2019 was $15.93M, a 6.15% decline from fiscal 2018.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, value, other for fiscal 2018 was $16.98M, a 9.65% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2023-06-30 | $9.79M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $770.00K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $23.16M 10-K · filed 2023-03-31 | |
| 2022-09-30 | $1.58M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $16.69M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $35.30M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $5.80M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $14.32M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $14.36M 10-Q · filed 2022-11-14 | |
| 2019-12-31 | $15.93M 10-K · filed 2020-05-08 | |
| 2019-09-30 | $444.00K 10-Q · filed 2020-10-23 | |
| 2019-06-30 | $15.11M 10-Q · filed 2020-10-23 | |
| 2019-03-31 | $380.11K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $16.98M 10-K · filed 2020-05-08 | |
| 2018-03-31 | $13.81M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $18.79M 10-K · filed 2019-03-15 | |
| 2016-12-31 | $16.02M 10-K · filed 2019-03-15 | |
| 2014-12-31 | $15.44M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |